About
Wolfgang is an Associate in our Global M&A and Capital practice focusing on life sciences, intellectual property, mergers and acquisitions, and capital markets matters.
Additional Information
- Insmed in the acquisition of an antibody program.
- Terns Pharmaceuticals on its $6.7 billion acquisition by Merck.
- Eli Lilly in its global strategic collaboration and licensing agreement with InduPro to discover novel oncology treatments using InduPro’s proximity-guided platform.
- SERB Pharmaceuticals on its exclusive license from Hansa Biopharma AB of development and commercialization rights to Idefirix® (imlifidase) in the European Union, United Kingdom, Switzerland, Norway, Liechtenstein, Iceland, and the Middle East and North Africa (MENA) region, and on its take-private of Y-mAbs Therapeutics.
- Merck on its $10 billion acquisition of Verona Pharma plc.
- Cullinan Therapeutics on its license agreement with Genrix Bio for ex-China rights to velinotamig, a clinical-stage bispecific T cell engager.
Wolfgang Paulson
Associate
New York Office
3 World Trade Center
175 Greenwich Street, 51st Floor
New York, NY 10007